Recorded Chinese product: 复方电解质葡萄糖注射液-R4A复方电解质葡萄糖注射液-R4A

This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。

Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。

生产企业Manufacturer

主要成分Active Ingredients

药物知识说明

氯化钠 钠 葡萄糖是一种在国家药监局注册认定的药品。标注生产企业为中国大冢制药有限公司。

该药品暂无关联的活性成分信息。

该药品标注的生产企业为:中国大冢制药有限公司Chinese legal name: 中国大冢制药有限公司、中国大冢制药有限公司Chinese legal name: 中国大冢制药有限公司、中国大冢制药有限公司Chinese legal name: 中国大冢制药有限公司。

本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。

Medicine Knowledge

This medicine (original name: 复方电解质葡萄糖注射液-R4A) is a medicine registered with the national drug regulatory authority. It is manufactured by Chinese legal name: 中国大冢制药有限公司.

No active ingredient relationships are currently recorded for this product in MedicineGraph.

Manufacturers recorded for this product: 中国大冢制药有限公司Chinese legal name: 中国大冢制药有限公司, 中国大冢制药有限公司Chinese legal name: 中国大冢制药有限公司, 中国大冢制药有限公司Chinese legal name: 中国大冢制药有限公司.

Source: MedicineGraph authoritative database. Relationships derived from registered product information.

这是什么What is this

  • 通用名/品名Recorded product name: 复方电解质葡萄糖注射液-R4ARecorded Chinese product: 复方电解质葡萄糖注射液-R4A
  • 规格Specification: 500ml500 mL

本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.

生产企业Manufacturer

  • 中国大冢制药有限公司Chinese legal name: 中国大冢制药有限公司

注册信息NMPA approval number

  • 批准文号NMPA approval number: 国药准字H10900048

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.

  • 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
  • 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.

本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.

English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.

NMPA approval number

国药准字H10900048

Manufacturer

Chinese legal name: 中国大冢制药有限公司 (domestically manufactured)

Indications

English translation unavailable. The original Chinese source label remains available below.

Dosage and administration

English translation unavailable. The original Chinese source label remains available below.

Adverse reactions

English translation unavailable. The original Chinese source label remains available below.

Contraindications

English translation unavailable. The original Chinese source label remains available below.

Precautions

English translation unavailable. The original Chinese source label remains available below.

Storage

Keep tightly closed.

Specification

English translation unavailable. The original Chinese source label remains available below.

中文说明书原文Original Chinese source label

批准文号

国药准字H10900048

生产企业

中国大冢制药有限公司(国产)

适应症

体液与电解质补充药。用于手术后早期及婴幼儿手术后的水分和电解质的补充,以及可能有钾潴留时的水分和电解质的补充。

用法用量

成人,一次500ml~1000ml静脉点滴。给药速度为每小时300ml~500ml(每分钟约80~130滴),小儿每小时50ml~100ml,并按年龄、症状、体重适当增减。

不良反应

急速大量给药时,有可能出现肺水肿、脑水肿、末梢水肿、水中毒。

禁忌

尚不明确。

注意事项

以下患者慎用:1? 肾功能不全患者。2? 高乳酸血症患者。3? 心功能不全患者。4? 严重肝功能不全患者。5? 因阻塞性尿路疾患而引起尿量减少的患者。6? 糖尿病患者。

贮藏

密闭保存。

规格

500ml

证据Evidence

  • 批准文号: 国药准字H10900048
  • rights: 本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.